1
|
Shin SH, Rantou E, Raney SG, Ghosh P, Hassan H, Stinchcomb A. Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average Bioequivalence. Pharm Res 2020; 37:210. [PMID: 33001286 DOI: 10.1007/s11095-020-02821-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Accepted: 04/09/2020] [Indexed: 11/25/2022]
Abstract
PURPOSE The in vitro permeation test (IVPT) with a new statistical approach was investigated to evaluate the utility of an IVPT methodology as a sensitive tool to support a demonstration of bioequivalence (BE) for topical dermatological drug products. METHODS IVPT experiments were performed utilizing ex vivo human skin. The initial screening tests involved four differently formulated acyclovir 5% creams: the U.S. Zovirax® as the reference product and the U.K. Zovirax®, Aciclovir 1A Pharma® and Aciclostad® as test products. Subsequently, a pivotal BE study was conducted comparing the two Zovirax® creams. The resulting data was used to evaluate BE of test (T) versus reference (R), T versus T, and R versus R, with an adaption of scaled average BE approach to address high variability in IVPT data. RESULTS More acyclovir permeated into and through the skin from the two Zovirax® creams compared to the two non-Zovirax® creams. The U.S. Zovirax® cream showed a significantly higher Jmax and total amount permeated over 48 h, compared to the U.K. Zovirax® cream. The statistical analysis indicated that the test and reference products were not bioequivalent, whereas each product tested against itself was shown to be bioequivalent. CONCLUSIONS The current study demonstrated that the IVPT method, with an appropriate statistical analysis of the results, is a sensitive and discriminating test that can detect differences in the rate and extent of acyclovir bioavailability in the skin from differently formulated cream products.
Collapse
Affiliation(s)
- Soo Hyeon Shin
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 N. Pine Street PHN521, MD, 21201, Baltimore, USA
| | - Elena Rantou
- Office of Biostatistics Office of Translational Sciences Center for Drug Evaluation and Research, United States Food and Drug Administration, White Oak Campus, MD, Silver Spring, USA
| | - Sam G Raney
- Office of Research and Standards Office of Generic Drugs Center for Drug Evaluation and Research, United States Food and Drug Administration, MD, 20993, Silver Spring, United States
| | - Priyanka Ghosh
- Office of Research and Standards Office of Generic Drugs Center for Drug Evaluation and Research, United States Food and Drug Administration, MD, 20993, Silver Spring, United States
| | - Hazem Hassan
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 N. Pine Street PHN521, MD, 21201, Baltimore, USA
- Department of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy, Helwan University, Cairo, Egypt
| | - Audra Stinchcomb
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 N. Pine Street PHN521, MD, 21201, Baltimore, USA.
| |
Collapse
|
2
|
Tiangco C, Andar A, Quarterman J, Ge X, Sevilla F, Rao G, Stinchcomb A, Bunge A, Tolosa L. Measuring transdermal glucose levels in neonates by passive diffusion: an in vitro porcine skin model. Anal Bioanal Chem 2017; 409:3475-3482. [PMID: 28283718 DOI: 10.1007/s00216-017-0289-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Revised: 02/01/2017] [Accepted: 02/28/2017] [Indexed: 11/30/2022]
Abstract
Current glucose monitoring techniques for neonates rely heavily on blood glucose monitors which require intermittent blood collection through skin-penetrating pricks on the heel or fingers. This procedure is painful and often not clinically conducive, which presents a need for a noninvasive method for monitoring glucose in neonates. Our motivation for this study was to develop an in vitro method for measuring passive diffusion of glucose in premature neonatal skin using a porcine skin model. Such a model will allow us to initially test new devices for noninvasive glucose monitoring without having to do in vivo testing of newborns. The in vitro model is demonstrated by comparing uncompromised and tape-stripped skin in an in-line flow-through diffusion apparatus with glucose concentrations that mimic the hypo-, normo-, and hyper-glycemic conditions in the neonate (2.0, 5.0, and 20 mM, respectively). Transepidermal water loss (TEWL) of the tape-stripped skin was approximately 20 g m-2 h-1, which closely mimics TEWL for neonatal skin at about 190 days post-conceptional age. The tape-stripped skin showed a >15-fold increase in glucose diffusion compared to the uncompromised skin. The very small concentrations of collected glucose were measured with a highly selective and highly sensitive fluorescent glucose biosensor based on the glucose binding protein (GBP). The demonstrated method of glucose determination is noninvasive and painless, which makes it especially desirable for glucose testing in neonates and children. This study is an important step towards an in vitro model for noninvasive real-time glucose monitoring that may be easily transferred to the clinic for glucose monitoring in neonates. Graphical Abstract Glucose diffusion through model skin was measured using an in-line flow-through diffusion apparatus with glucose solutions mimicking hypo-, normo- and hyperglycemia in the neonate. Phosphate buffered saline was added to the top chamber and the glucose that diffused through the model skin into the buffer was measured using a fluorescent glucose binding protein biosensor.
Collapse
Affiliation(s)
- Cristina Tiangco
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA.,The Graduate School, University of Santo Tomas, España Boulevard, 1015, Manila, Philippines
| | - Abhay Andar
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA.,Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, Baltimore, MD, 21201, USA
| | - Juliana Quarterman
- Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, Baltimore, MD, 21201, USA
| | - Xudong Ge
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA
| | - Fortunato Sevilla
- The Graduate School, University of Santo Tomas, España Boulevard, 1015, Manila, Philippines
| | - Govind Rao
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA
| | - Audra Stinchcomb
- Department of Pharmaceutical Sciences, University of Maryland, 20 North Pine Street, Baltimore, MD, 21201, USA
| | - Annette Bunge
- Chemical and Biological Engineering Department, Colorado School of Mines, 1500 Illinois Street, Golden, CO, 80401, USA
| | - Leah Tolosa
- Center for Advanced Sensor Technologycsm, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD, 21250, USA.
| |
Collapse
|
3
|
Weiss F, Martin-Fardon R, Gonzales-Cuevas G, Stinchcomb A. SY40-4 * CANNABIDIOL: LONG-LASTING AMELIORATION OF VULNERABILITY STATES ASSOCIATED WITH RELAPSE RISK AS DETERMINED IN ANIMAL MODELS OF DRUG SEEKING, ANXIETY, AND IMPULSIVITY. Alcohol Alcohol 2014. [DOI: 10.1093/alcalc/agu052.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
4
|
Strasinger C, Paudel KS, Wu J, Hammell D, Pinninti RR, Hinds B, Stinchcomb A. Programmable transdermal clonidine delivery through voltage-gated carbon nanotube membranes. J Pharm Sci 2014; 103:1829-38. [PMID: 24788096 PMCID: PMC4218846 DOI: 10.1002/jps.23940] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2014] [Revised: 02/06/2014] [Accepted: 02/07/2014] [Indexed: 11/07/2022]
Abstract
Oral dosage forms and traditional transdermal patches are inadequate for complex clonidine therapy dosing schemes, because of the variable dose/flux requirement for the treatment of opioid withdrawal symptoms. The purpose of this study was to evaluate the in vitro transdermal flux changes of clonidine in response to alterations in carbon nanotube (CNT) delivery rates by applying various electrical bias. Additional skin diffusion studies were carried out to demonstrate the therapeutic feasibility of the system. This study demonstrated that application of a small electrical bias (-600 mV) to the CNT membrane on the skin resulted in a 4.7-fold increase in clonidine flux as compared with no bias (0 mV) application. The high and low clonidine flux values were very close to the desired variable flux of clonidine for the treatment of opioid withdrawal symptoms. Therapeutic feasibility studies demonstrated that CNT membrane served as the rate-limiting step to clonidine diffusion and lag and transition times were suitable for the clonidine therapy. Skin elimination studies revealed that clonidine depletion from the skin would not negatively affect clonidine therapy. Overall, this study showed that clonidine administration difficulties associated with the treatment of opiate withdrawal symptoms can be reduced with the programmable CNT membrane transdermal system.
Collapse
Affiliation(s)
| | - Kalpana S Paudel
- College of Pharmacy, University of Kentucky, Lexington, KY
- South College School of Pharmacy, Knoxville, TN
| | - Ji Wu
- Department of Chemical and Materials Engineering, University of Kentucky, Lexington, KY
| | - Dana Hammell
- College of Pharmacy, University of Kentucky, Lexington, KY
- AllTranz Inc, Lexington, KY
| | | | - Bruce Hinds
- Department of Chemical and Materials Engineering, University of Kentucky, Lexington, KY
| | - Audra Stinchcomb
- College of Pharmacy, University of Kentucky, Lexington, KY
- School of Pharmacy, University of Maryland, Baltimore, MD
- AllTranz Inc, Lexington, KY
| |
Collapse
|
5
|
Abstract
The effects of ethanol and diazepam were examined in long-sleep (LS) and short-sleep (SS) mice using the elevated plus-maze. Ethanol had more pronounced effects in SS mice than in LS mice. In contrast, LS mice were more sensitive to the effects of diazepam on the elevated plus-maze. The ataxic effects of ethanol were measured by rotarod performance. SS mice were more resistant to the ataxic effects of a 2.0 g/kg dose of ethanol than LS mice. Ro 15-4513 reversed ethanol's ataxic effects when administered after ethanol in both LS mice and SS mice. Pentobarbital-induced ataxia was unaffected by treatment with Ro 15-4513. Studies of competition of Ro 15-4513 on 3H-flunitrazepam binding indicated that LS and SS mice did not differ in this measure in cortex, cerebellum or hippocampus.
Collapse
Affiliation(s)
- A Stinchcomb
- Institute for Behavioral Genetics, University of Colorado, Boulder 80309
| | | | | |
Collapse
|
6
|
Abstract
Molecular and conformational characteristics of benzodiazepine (BZ) receptors in cortex and cerebellum from long-sleep and short-sleep mice were investigated using heat inactivation and beta-carboline competition techniques. To investigate differences in the allosteric coupling between GABA and BZ receptors, the protection of BZ receptors from heat inactivation, by GABA, was also evaluated. The two genotypes do not differ in the affinity or number of BZ receptors in the cortex or cerebellum. They do, however, appear to differ in the molecular structure and/or regulation of the conformational state of the receptor in the cortex, as indicated by a greater sensitivity of LS mice to both heat inactivation and beta-carboline competition of 3H-flunitrazepam (FNZ) binding in this region. Evidence for differences in the nature of coupling between GABA and BZ receptors is provided by the finding that in both regions, GABA protected BZ receptors from inactivation to a greater degree in LS mice. The relationship between these differences and the multiplicity of expression of BZ receptors is discussed.
Collapse
Affiliation(s)
- R J Marley
- Institute for Behavioral Genetics, University of Colorado, Boulder 80309
| | | | | |
Collapse
|